Trends in the incidence and prevalence of cardiac pacemaker insertions in an ageing population

Open Heart

Volumn 1, Issue 1, 2014, Pages

  Bradshaw, Pamela J ^a   Stobie, Paul ^b   Knuiman, Matthew W ^a   Briffa, Thomas G ^a   Hobbs, Michael S T ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; AGING; ARTICLE; ARTIFICIAL HEART PACEMAKER; ATRIAL FIBRILLATION; ATRIOVENTRICULAR BLOCK; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DEATH; DEFIBRILLATOR PACEMAKER; DUAL CHAMBER PACEMAKER; FEMALE; HEART BUNDLE BRANCH BLOCK; HEART PACING; HUMAN; ICD-10; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY RATE; OBSERVATIONAL STUDY; POPULATION RESEARCH; PREVALENCE; REGISTER; RETROSPECTIVE STUDY; SEX DIFFERENCE; SICK SINUS SYNDROME; TREATMENT INDICATION; TREND STUDY; VERY ELDERLY; WESTERN AUSTRALIA;

EID: 84984661271     PISSN: None     EISSN: 20533624     Source Type: Journal    
DOI: 10.1136/openhrt-2014-000177     Document Type: Article

References (37)

1. Gregoratos G. Permanent pacemakers in older persons. J Am Geriatr Soc 1999;47:1125-35.
2. United Nations, Department of Economic and Social Affairs, Population Division. World Population Ageing: 1950-2050. New York, 2001. http://www.un.org/esa/population/publications/worldageing19502050/
3. Mond HG. The World Survey of Cardiac Pacing and Implantable Cardioverter-Defibrillators: calendar year 1997. Asian Pacific, Middle East, South America, and Canada. Pacing Clin Electrophysiol 2001;24:856-62.
4. Ector H. Rickards AF, Kappenberger L, et al. The World Survey of Cardiac Pacing and Implantable Cardioverter-Defibrillators: calendar year 1997-Europe. Pacing Clin Electrophysiol 2001;27:863-8.
5. Mond HG, Irwin M, Morillo C, et al. The World Survey of Cardiac Pacing and Cardioverter-Defibrillators: calendar year 2001. Pacing Clin Electrophysiol 2004;27:955-64.
6. Mond HG, Irwin M, Ector H, et al. The World Survey of Cardiac Pacing and Cardioverter-Defibrillators: calendar year 2005. PACE 2008;31:1202-12.
7. Mond HG, Proclemer A. The 11th World Survey of Cardiac Pacing and Cardioverter-Defibrillators: calendar year 2009. Pacing Clin Electrophysiol 2011;34:1013-27.
8. Ector H, Vardas P. Current use of pacemakers, implantable cardioverter defibrillators, and resynchronization devices: data from the registry of the European Heart Rhythm Association. Eur Heart J Suppl 2007:9(Suppl 1):144-9.
9. Silverman BG, Gross TP, Kaczmarek RG, et al. The epidemiology of pacemaker insertion in the United States. Public Health Rep 1995;110:42-6.
10. Andersen C, Green A, Madsen GM, et al. The epidemiology of pacemaker insertions in Fyn county, Denmark. Pacing Clin Electrophysiol 1991;14:1614-21.
11. Brown D, Croft J, Giles W, et al. Epidemiology of pacemaker procedures among Medicare enrollees in 1990, 1995, and 2000. Am J Cardiol 2005;95:409-11.
12. Bradshaw PJ, Stobie P, Briffa T, et al. Use and long-term outcomes of implantable cardioverter-defibrillators, 1990 to 2009. Am Heart J 2013;65:816-22.
13. Holman C, Bass A, Rouse I, et al. Population-based linkage of health records in Western Australia: development of a health services research linked database. Aust NZ J Public Health 1999;23:453-9.
14. Mond HG, Whitlock RML. The Australian and New Zealand Cardiac Pacing and Implantable Cardioverter-Defibrillator Survey: calendar year 1997. Intern Med J 2001;31:267-71.
15. Mond HG, Whitlock RML. The Australian and New Zealand Cardiac Pacing and Implantable Cardioverter-Defibrillator Survey: calendar year 2001. Heart Lung Circ 2004;13:145-9.
16. Mond HG, Whitlock RML. The Australian and New Zealand Cardiac Pacing and Implantable Cardioverter-Defibrillator Survey: calendar year 2005. Heart Lung Circ 2008;17:85-9.
17. Mond HG, Whitlock RML. The Australian and New Zealand Cardiac Pacing and Implantable Cardioverter-Defibrillator Survey: calendar year 2009. Heart Lung Circ 2011;20:99-104.
18. Australian Bureau of Statistics 3235.0-2009. Population by Age and Sex, Regions of Australia. http://www.abs.gov.au/ausstats/abs@.nsf/Products/3235.0~2009~Main+Features~Western+Australia
19. Australian Bureau of Statistics 3101.0 - Australian Demographic Statistics, June 1990 PDF http://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/3101.0Jun%201990
20. Tuppin P, Neumann A, Marijon E, et al. Insertion and patient profiles for pacemakers and cardioverter-defibrillators in France (2008-2009). Arch Cardiovasc Dis 2011;104:332-42.
21. Uslan D, Tleyjeh I, Baddour L, et al. Temporal trends in permanent pacemaker insertion: a population-based study. Am Heart J 2008;155:896-903.
22. Australian Bureau of Statistics. Deaths, Australia, 2010. Cat. No. 3302.0 http://www.abs.gov.au/ausstats/abs@.nsf/Products/3302.0~2010~Chapter~Main+Features?OpenDocument
23. Chow GV, Marine JE, Fleg JL. Epidemiology of arrhythmias and conduction disorders in older adults. Clin Geriatr Med 2012;28:539-53.
24. Zhan C, Baine WB, Sedrakyan A, et al. Cardiac device insertion in the United states from 1997 through 2004: a population-based analysis. J Gen Intern Med 2008;23(Suppl 1):13-19.
25. Birnie D, Williams K, Guo A, et al. Reasons for escalating pacemaker implants. Am J Cardiol 2006;98:93-7.
26. Schuchert A, Muto C, Maounis T, et al. for the MASCOT study group. Lead complications, device infections, and clinical outcomes in the first year after implantation of cardiac resynchronization therapy-defibrillator and cardiac resynchronization therapy-pacemaker. Europace 2013;15:71-6.
27. Ahsan S, Saberwal B, Lamblase P, et al. An 8-year single-centre experience of cardiac resynchronisation therapy: procedural success, early and late complications, and left ventricular lead performance. Europace 2013;15:711-17.
28. Gadler F, Valzania C, Linde C. Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry. Europace Published Online First: 21 Oct 2014.
29. Urra FG, Lezcano AO. MAMI registration report 1996-2010. Cardiol J 2012;19:603-11.
30. Proclemer A, Ghidina M, Gregori D, et al. Trend of the main clinical characteristics and pacing modality in patients treated by pacemaker: data from the Italian Pacemaker Registry for the quinquennium 2003-07. Europace 2010;12:202-9.
31. Coma Samartín R, Martínez Ferrer J, Sancho Tello MJ, et al. Spanish pacemaker registry. Fifth official report of the Spanish Society of Cardiology Working Group on Cardiac Pacing (2007). Rev Esp Cardiol (Engl Ed) 2008;61:1315-28.
32. World Population Ageing. Population Division, Department of Economic and Social Affairs. United Nations, New York 2009. http://www.un.org/esa/population/publications/WPA2009/WPA2009-WorkingPaper.pdf
33. Merkely B, Roka A, Kutyifa V, et al. Tracing the European course of cardiac resynchronization therapy from 2006 to 2008. Europace 2010;12:692-701.
34. Khazanie P, Hammill BG, Qualls LG, et al. Clinical effectiveness of cardiac resynchronization therapy vs medical therapy alone among patients with heart failure: an analysis of the ICD and ADHERE national registries. Circ Heart Fail 2014;7:926-34.
35. Kurtz SM, Ochoa JA, Lau E, et al. Implantation trends and patients profiles for pacemakers and implantable cardioverter defibrillators in the United Sates: 1993-2006. Pacing Clin Electrophysiol 2010;33:705-11.
36. Bradshaw PJ, Jamrozik K, Jelfs P, et al. Mobile Australians: a moving target for epidemiologists. Med J Aust 2000;172:566.
37. Teng TH, Finn J, Hung J, et al. A validation study: how effective is the Hospital Morbidity Data as a surveillance tool for heart failure in Western Australia? Aust N Z J Public Health 2008;32:405-7.